Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China

Melanoma is a rare malignant tumor in China; however, its mortality rate is high and the incidence rate is also increasing year by year. In order to improve the efficacy of melanoma treatment, the National Health Commission of the People’s Republic of China revised Chinese guidelines for diagnosis and treatment of melanoma in 2018, and meanwhile its modified English version Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version) is also published. Based on the most updated research findings for the Chinese ethnicity with emphasis on acral and mucosal melanomas, two most commonly seen subtypes in Asia, as well as treatment for melanoma liver metastases. The guideline, with its well-organized structure, concisely-written sentences and easily understandable language, helps medical staffs and patients from other parts of the world understand better what our extensive experience is in terms of treating melanoma subtypes that are rarely seen in the Caucasian population.

PDF阅读